During the past decade, Inha university hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Inha university hospital" #1 sponsor was "Bukwang Pharmaceutical" with 4 trials, followed by "Pfizer" with 4 trials sponsored, "Hyundai Pharmaceutical Co., LTD." with 3 trials sponsored, "Alvogen Korea" with 1 trials sponsored and "AstraZeneca" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Inha university hospital" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Ewha Womans University Mokdong Hospital" with 1 trials as a collaborator, "Gachon University Gil Medical Center" with 1 trials as a collaborator and "Hanyang University Seoul Hospital" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Inha university hospital" are "Hepatitis B" (4 trials), "Osteoporosis" (2 trials), "Alopecia Areata" (1 trials), "Alzheimer's Disease" (1 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Inha university hospital" in a lesser frequency.

Most popular intervention types in "Inha university hospital" are "Drug" (15 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Clevudine" (2 trials), "Adalimumab with methotrexate" (1 trials), "Amlodipine" (1 trials) and "Baricitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Inha university hospital" are 13 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Inha university hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Inha university hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Inha university hospital, 4 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".